CD9 Antibody (MM2/57) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-28364
Clone MM2/57 was used by HLDA to establish CD designation.
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Canine, Feline, Hamster, Monkey, Rabbit
Cited:
Feline
Applications
Validated:
Flow Cytometry
Cited:
Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # MM2/57
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen is a peptide made to the amino acid region CD9
Reactivity Notes
Raccoon (100%). Use in Mouse reported in scientific literature (PMID:32573489).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Scientific Data Images for CD9 Antibody (MM2/57) [FITC]
Flow Cytometry: CD9 Antibody (MM2/57) [FITC] [NBP1-28364] - Human peripheral blood platelets were stained with Mouse Anti-Human CD9-FITC
Flow Cytometry: CD9 Antibody (MM2/57) [FITC] [NBP1-28364] - Analysis of peripheral blood lymphocytes.
Applications for CD9 Antibody (MM2/57) [FITC]
Application
Recommended Usage
Flow Cytometry
10 uL/10^6 cells
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS containing < 0.1% sodium azide
Preservative
Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: CD9
Alternate Names
CD9, DRAP-27, MIC3, p24, TSPAN29
Gene Symbol
CD9
Additional CD9 Products
Product Documents for CD9 Antibody (MM2/57) [FITC]
Product Specific Notices for CD9 Antibody (MM2/57) [FITC]
Protect conjugated forms from light.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...